Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-21-002288
Filing Date
2021-03-03
Accepted
2021-03-03 08:02:07
Documents
100
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K sbbp-20201231x10k.htm   iXBRL 10-K 3080712
2 EX-21.1 sbbp-20201231xex21d1.htm EX-21.1 2156
3 EX-23.1 sbbp-20201231xex23d1.htm EX-23.1 2973
4 EX-31.1 sbbp-20201231xex31d1.htm EX-31.1 11717
5 EX-31.2 sbbp-20201231xex31d2.htm EX-31.2 11705
6 EX-32.1 sbbp-20201231xex32d1.htm EX-32.1 10451
7 GRAPHIC sbbp-20201231x10k005.jpg GRAPHIC 35584
8 GRAPHIC sbbp-20201231x10k006.jpg GRAPHIC 22022
9 GRAPHIC sbbp-20201231x10k007.jpg GRAPHIC 29619
10 GRAPHIC sbbp-20201231x10k008.jpg GRAPHIC 42009
  Complete submission text file 0001558370-21-002288.txt   11520768

Data Files

Seq Description Document Type Size
11 EX-101.SCH sbbp-20201231.xsd EX-101.SCH 67582
12 EX-101.CAL sbbp-20201231_cal.xml EX-101.CAL 80504
13 EX-101.DEF sbbp-20201231_def.xml EX-101.DEF 225390
14 EX-101.LAB sbbp-20201231_lab.xml EX-101.LAB 632928
15 EX-101.PRE sbbp-20201231_pre.xml EX-101.PRE 478937
16 EXTRACTED XBRL INSTANCE DOCUMENT sbbp-20201231x10k_htm.xml XML 2122006
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

EIN.: 981130690 | State of Incorp.: L2
Type: 10-K | Act: 34 | File No.: 001-37569 | Film No.: 21707268
SIC: 2834 Pharmaceutical Preparations